We are live on
!
Find out more
KA
Keene & Associates Portfolio holdings
AUM
$125M
1-Year Est. Return
13.49%
This Fund
S&P 500
This Quarter
Est. Return
+6.8%
1 Year Est. Return
+13.49%
3 Year Est. Return
+20.33%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$134M
AUM Growth
+$13.4M
(+11%)
Cap. Flow
+$5.63M
Cap. Flow
% of AUM
4.21%
Top 10 Holdings %
Top 10 Hldgs %
30.08%
Holding
84
New
4
Increased
49
Reduced
18
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Evergy
EVRG
|
+$3.32M |
| 2 |
Pfizer
PFE
|
+$1.33M |
| 3 |
Newmont
NEM
|
+$774K |
| 4 |
B
Barrick Mining
B
|
+$644K |
| 5 |
Bristol-Myers Squibb
BMY
|
+$572K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Organon & Co
OGN
|
+$1.08M |
| 2 |
Intel
INTC
|
+$1.01M |
| 3 |
Vistra
VST
|
+$513K |
| 4 |
PIMCO Ultra Short Government Active ETF
BILZ
|
+$466K |
| 5 |
Elanco Animal Health
ELAN
|
+$441K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 19.33% |
| 2 | Healthcare | 15.26% |
| 3 | Technology | 15.03% |
| 4 | Materials | 10.09% |
| 5 | Energy | 9.87% |
Similar funds
SSF
EECFI
TC
P2P
HGERS
GC
WI
NBT
Keene & Associates's Q1 2024 Portfolio in Review
As of Q1 2024, Keene & Associates held 84 positions worth $134M, up 11% from $120M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Keene & Associates deployed $5.63M of net new capital in Q1 2024, opening 4 new positions and adding to 49 existing holdings. Its largest new stake was Evergy: 64,935 shares worth $3.47M.
By sector, the portfolio is most concentrated in Consumer Staples at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Intel, an estimated $1.01M trimmed.
- Keene & Associates's largest Q1 2024 buy was Evergy: 64,935 shares worth $3.47M.
- Keene & Associates added most to Pfizer in Q1 2024, an estimated $1.33M increase.
- Keene & Associates's biggest Q1 2024 reduction was Intel, cutting an estimated $1.01M.
- Keene & Associates fully exited Organon & Co in Q1 2024, selling an estimated $1.08M.
- Keene & Associates's ten largest holdings make up 30% of its $134M portfolio in Q1 2024.
- Keene & Associates opened 4 new positions and closed 2 in Q1 2024.
- Keene & Associates's portfolio value rose 11% quarter-over-quarter to $134M.
Based on Keene & Associates's 13F filing for Q1 2024, filed 24 Apr 2024.